These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


267 related items for PubMed ID: 1374142

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Factors affecting size and configuration of neodymium:YAG (Nd:YAG) laser lesions in the prostate.
    Fournier GR, Narayan P.
    Lasers Surg Med; 1994; 14(4):314-22. PubMed ID: 7521504
    [Abstract] [Full Text] [Related]

  • 5. Nd:YAG laser ablation plus transurethral resection for large prostates in high-risk patients.
    Gürdal M, Tekin A, Yücebaş E, Sengör F.
    Urology; 2003 Nov; 62(5):914-7. PubMed ID: 14624919
    [Abstract] [Full Text] [Related]

  • 6. Contact laser vaporization techniques for benign prostatic hyperplasia.
    Gomella LG, Lotfi MA, Rivas DA, Chancellor MB.
    J Endourol; 1995 Apr; 9(2):117-23. PubMed ID: 7543321
    [Abstract] [Full Text] [Related]

  • 7. Transurethral evaporation of prostate (TUEP) with Nd:YAG laser using a contact free beam technique: results in 61 patients with benign prostatic hyperplasia.
    Narayan P, Fournier G, Indudhara R, Leidich R, Shinohara K, Ingerman A.
    Urology; 1994 Jun; 43(6):813-20. PubMed ID: 7515205
    [Abstract] [Full Text] [Related]

  • 8. Use of bare fiber with siderfiring Albarran bridge in laser therapy of the prostate.
    Mattioli S.
    J Endourol; 1995 Apr; 9(2):125-7. PubMed ID: 7543322
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
    Tan AH, Gilling PJ, Kennett KM, Frampton C, Westenberg AM, Fraundorfer MR.
    J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intermediate-term efficacy of Tm:YAG laser prostate vaporesection for bladder outlet obstruction: initial experience from a UK teaching hospital.
    Pal RP, Khan MA.
    Urol Int; 2012 Oct; 88(1):39-42. PubMed ID: 22133639
    [Abstract] [Full Text] [Related]

  • 16. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia.
    Cowles RS, Kabalin JN, Childs S, Lepor H, Dixon C, Stein B, Zabbo A.
    Urology; 1995 Aug; 46(2):155-60. PubMed ID: 7542818
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM, Elmansy HM, Elhilali MM.
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [Abstract] [Full Text] [Related]

  • 19. Lasers in the treatment of benign prostatic obstruction: past, present, and future.
    te Slaa E, de la Rosette JJ.
    Eur Urol; 1996 Dec; 30(1):1-10. PubMed ID: 8854060
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.